Recalls / Active ingredient / Cisatracurium Besylate
Cisatracurium Besylate
5 FDA drug recalls involving the active ingredient “Cisatracurium Besylate” — 1 Class I.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2025-11-26 | Class III | Cisatracurium Besylate Injection USP, 200mg/20mL*(10mg/mL), 10 x 20 mL Single-dose Vials per Carton, Rx Only, | SOMERSET THERAPEUTICS LLC |
| 2025-11-26 | Class III | Cisatracurium Besylate Injection USP, 10 mg/5 mL* (2mg/mL), 10 x 5 mL Single-dose Vials per Carton, Rx Only, M | SOMERSET THERAPEUTICS LLC |
| 2025-11-26 | Class III | Cisatracurium Besylate Injection USP, 20 mg/10 mL*,(2 mg/mL), 10 x 10 mL Multiple-dose Vials per carton, Rx On | SOMERSET THERAPEUTICS LLC |
| 2021-01-27 | Class I | Cisatracurium Besylate Injection, USP, 10mg per 5mL (2 mg per mL), Single-Dose Vial (NDC 71288-712-05), packag | Meitheal Pharmaceuticals Inc |
| 2016-04-05 | Class II | Cisatracurium Besylate Injection, 20 mg per 10 mL (2 mg per mL), For intravenous injection, 10 mL Multiple Dos | Fresenius Kabi USA, LLC |